The Medicap Healthcare IPO is now ₹170 crore, a 29% cut from the ₹240 crore in its draft papers. It has also dropped the pre-IPO placement, as per an addendum dated 21 November.
No price band or opening date has been announced. You can follow the company on our upcoming mainboard IPO page.
What has changed in the offer?
The company's board decided on 15 November to reduce the issue. The offer was entirely a fresh issue and stays that way. There is no offer for sale (OFS), so no selling shareholder takes money out.
| Item | DRHP | Revised |
|---|---|---|
| Issue size | ₹240 crore | ₹170 crore |
| Pre-IPO placement | Up to ₹48 crore | Dropped |
| Structure | Fresh issue only | Fresh issue only |
The cut is ₹70 crore. A pre-IPO placement is a private sale of shares to select investors before the public issue. That option is now off the table.
Why could it cut the size without refiling?
SEBI rules let a company raise or lower its fresh issue by up to 50% without filing its draft offer document (DRHP) again. This relaxation applies to IPOs opening on or before 31 March 2027.
Medicap filed its draft papers in September 2025. SEBI approved them in January 2026.
What will the money be used for?
The company has revised how it will use the money. Of the net proceeds, ₹83 crore is for plant and machinery at its existing Vadodara unit. Another ₹44 crore goes to repay debt. The rest is for general corporate purposes.
Medicap makes pharmaceutical closures, such as Euro Head caps, and bottle preforms. It plans 29 more injection moulding machines at the same unit.
What our data shows
The factory made about 45 crore units in FY26 against a capacity of about 80 crore. That is roughly 56% of capacity in use.
Debt was ₹244.9 crore on a consolidated basis as of 15 November 2026. On a standalone basis it was ₹36.2 crore.
What happens next?
Medicap must still file its red herring prospectus (RHP), the final offer document, and announce a price band before the IPO can open. Aryaman Financial Services is the merchant banker. We will cover the dates once they are announced. Past mainboard listings are on our IPO performance page. The figures above are from a Moneycontrol report on the addendum.